In both breast and pancreatic cancer cells, we observed a significant negative correlation between ACVR1B expression and ACVR1B methylation levels (Supplementary Fig. 2c, d), suggesting that ACVR1B methylation is a critical mechanism driving ACVR1B silencing. Here, ACVR1B is linked to familial pancreatic carcinoma.